5.73
0.00
(0.00%)
At close: January 10 at 8:05:04 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-320,153.00
-540,585.00
-460,036.00
-378,182.00
664,280.00
Investing Cash Flow
262,165.00
442,913.00
325,433.00
-1,002,448.00
442,684.00
Financing Cash Flow
10,403.00
6,027.00
3,070.00
13,334.00
426,762.00
End Cash Position
102,459.00
72,324.00
163,969.00
295,502.00
1,662,798.00
Capital Expenditure
--
-553.00
-937.00
-372.00
-345.00
Issuance of Capital Stock
--
--
--
--
417,500.00
Free Cash Flow
-320,041.00
-541,138.00
-460,973.00
-378,554.00
663,935.00
12/31/2020 - 12/11/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6C1.SG CytomX Therapeutics Inc
0.8410
-9.52%
41O.F Outlook Therapeutics, Inc.
2.0600
+0.98%
4A3.F Immatics N.V.
6.84
+1.71%
05Y.F Vivoryon Therapeutics N.V.
2.0200
+1.51%
BVNKF Bavarian Nordic A/S
26.25
0.00%
VVY.AS Vivoryon Therapeutics N.V.
1.9900
-1.49%
POLB.L Poolbeg Pharma PLC
5.15
-8.04%
PHARM.AS Pharming Group N.V.
0.9105
-2.10%